Table 1.

Correlation between BAP1 expression and clinicopathologic characteristics in 214 ICC patients

Clinicopathological indexes	BAP1
	Low	High	P value*
Age (year)
≤50	47	40	0.945
>50	68	59
Sex
Female	51	28	0.015
Male	64	71
HBsAg
Negative	66	46	0.111
Positive	49	53
AFP (ng/ml)
≤20	89	73	0.534
>20	26	26
CA19-9 (U/ml)
<37	42	59	0.001
≥37	73	40
ALT (U/l)
≤75	96	86	0.488
>75	19	13
Liver cirrhosis
No	104	84	0.212
Yes	11	15
Tumor size (cm)
≤5	37	49	0.010
>5	78	50
Tumor number
Single	106	87	0.292
Multiple	9	12
Tumor encapsulation
Complete	19	25	0.115
None	96	74
Lymphatic metastasis
No	79	88	0.000
No	36	11
Vascular invasion
No	91	84	0.280
Yes	24	15
Tumor differentiation
I–II	77	69	0.668
III–IV	38	30
TNM stage
I	44	57	0.005
II–III	71	42

AFP α-fetoprotein, CA19-9 carbohydrate antigen 19-9, ALT alanine aminotransferase

* χ² tests for all analysis

P < 0.05, which indicate significantly difference